In line with these findings, recent evidence suggests DDAH1 is expressed in prostasomes derived from prostate cancer metastases47 and is upregulated in metastatic malignant melanoma48, whilst over-expression of DDAH1 results in increased tumour growth, vascularization and elevated VEGF secretion in vivo49,50. The gene discussed is DDAH1; the disease is prostate cancer.